Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
A Safety Analysis of Programmed Death 1 Pathway Inhibitors in Patients With Solid Tumor Malignancies and Preexisting Autoimmune Disease.
Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
Published: June 13, 2022
A Phase 2 Study of Docetaxel, Ramucirumab, and Pembrolizumab for Patients With Metastatic or Recurrent Non-Small-Cell Lung Cancer (NSCLC) who Progressed on Platinum-Doublet and PD-1/PD-L1 Blockade.
Journal: Clinical lung cancer
Published: May 05, 2022
Durvalumab and tremelimumab with or without stereotactic body radiation therapy in relapsed small cell lung cancer: a randomized phase II study.
Journal: Journal for immunotherapy of cancer
Published: November 15, 2020
Phase Ib Study of Crizotinib plus Pembrolizumab in Patients with Previously Untreated Advanced Non-Small Cell Lung Cancer with ALK Translocation.
Journal: The oncologist
Published: November 21, 2019
Trimodality Therapy in the Treatment of Stage III N2-Positive Non-Small Cell Lung Cancer: A National Cancer Database Analysis.
Journal: The oncologist
Published: August 28, 2019
Survival Outcomes With Thoracic Radiotherapy in Extensive-Stage Small-Cell Lung Cancer: A Propensity Score-Matched Analysis of the National Cancer Database.
Journal: Clinical lung cancer
Published: April 07, 2019
Personalized therapy for lung cancer: striking a moving target.
Journal: JCI insight
Published: August 10, 2018
Immune checkpoint inhibitors in small cell lung cancer.
Journal: Journal of thoracic disease
Published: March 30, 2018
Concomitant Chemotherapy and Radiotherapy with SBRT Boost for Unresectable Stage III Non-Small Cell Lung Cancer: A Phase I Study.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: July 01, 2017
Comparison of the toxicity profile of PD-1 versus PD-L1 inhibitors in non-small cell lung cancer: A systematic analysis of the literature.
Journal: Cancer
Published: March 13, 2017
Comparison of Concurrent Use of Thoracic Radiation With Either Carboplatin-Paclitaxel or Cisplatin-Etoposide for Patients With Stage III Non-Small-Cell Lung Cancer: A Systematic Review.
Journal: JAMA oncology
Published: December 16, 2016
Concurrent chemoradiotherapy with weekly versus triweekly cisplatin in locally advanced squamous cell carcinoma of the head and neck: Comparative analysis.
Journal: Head & neck
Published: December 13, 2016
Last Updated: 09/26/2026